Single dose of zilebesiran safely and effectively lowered blood pressure for six months
November 11, 2023
November 11, 2023
DALLAS, Texas, Nov. 11 [Category: Health Care] -- The American Heart Association issued the following news release:
Research Highlights:
The phase 2 study found that a single injection of the experimental medication zilebesiran safely and effectively lowered blood pressure in adults with mild-to-moderate hypertension for up to six months.
Based on these results, zilebesiran has the potential to improve medication adherence due to infrequent dosing, which wi . . .
Research Highlights:
The phase 2 study found that a single injection of the experimental medication zilebesiran safely and effectively lowered blood pressure in adults with mild-to-moderate hypertension for up to six months.
Based on these results, zilebesiran has the potential to improve medication adherence due to infrequent dosing, which wi . . .